Yingcheng Wei

GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma

Wenliang Tan, Kelin Zhang, Xinming Chen et al. · Journal of Advanced Research · 2022 · 49 citations · Full text

miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1

Wenliang Tan, Zhirong Lin, Xianqing Chen et al. · Annals of Translational Medicine · 2021 · 25 citations · Full text

CircLIFR suppresses hepatocellular carcinoma progression by sponging miR-624-5p and inactivating the GSK-3β/β-catenin signaling pathway

Lei Yang, Wenliang Tan, Yingcheng Wei et al. · Cell Death and Disease · 2022 · 24 citations · Full text

circCCNY enhances lenvatinib sensitivity and suppresses immune evasion in hepatocellular carcinoma by serving as a scaffold for SMURF1 mediated HSP60 degradation

Lei Yang, Wenliang Tan, Min Wang et al. · Cancer Letters · 2025 · 14 citations